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The aim of this study was to investigate the effect of gels containing the monoterpene borneol in induced 
oral mucositis using an animal model. Gels were prepared with borneol at 1.2% and 2.4% (w/w). Oral 
mucositis was induced by administration of three doses of 5-fluorouracil (30 mg/kg, i.p.) and injury 
with acetic acid (50%, v/v) soaked in filter paper applied to right cheek mucosa for 60s. Four subgroups 
comprising 12 animals each were formed. Six animals from each group were sacrificed at days seven and 
fourteen after oral mucositis induction. Mucous samples were processed and stained with hematoxylin-
eosin and Masson’s Trichrome. The semiquantitative evaluation involved observation of inflammatory 
parameters. ImageJ® software was used in the quantitative evaluation. For statistical analyses, Two-way 
ANOVA, followed by Tukey’s post-test (p <0.05), were employed. Borneol 2.4% gel proved effective in 
the treatment of oral mucositis with statistically significant differences between groups for angiogenesis 
control, inflammatory cell count reduction and percentage neoformed collagen increase. The confirmation 
of anti-inflammatory and healing action of borneol in oral mucositis in rats renders it a good marker for 
predicting this activity for plant extracts rich in this substance.
Keywords: Chemotherapy. Oral gel/Borneol monoterpene/effects. Oral gel/Borneol monoterpene/action 
anti-inflammatory. Oral gel/Borneol monoterpene/healing action. Bornyl alcohol/effects. Palliative care.
INTRODUCTION
The clinical manifestations most commonly 
associated with treatment of cancer of the oral cavity 
are oral mucositis (OM), osteoradionecrosis, dry mouth, 
radiation caries, trismus, opportunistic infections 
and dysphagia, among others. OM is an important 
complication of oncological treatments such as head and 
neck radiotherapy, chemotherapy and Hematopoietic Stem 
Cell Transplantation (HSCT), autologous or allogeneic, 
having a prevalence of 75%–99%. (Simões, Castro, Cazal, 
2011; Patussi et al., 2014). Therefore, the healthcare team 
should have a broad knowledge of all oral complications 
of anticancer therapy in order to improve patients´ quality 
of life (Sera et al., 2013).
Among the different oral manifestations, mucositis 
is the most common and distressing condition that 
develops as an acute adverse effect of chemotherapy 
and radiotherapy of the head and neck and is one of the 
leading causes of disability that limits cancer therapy 
dose. This complication leads to therapy alteration, 
dose reduction, delay, interruption or termination and 
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can negatively affect the healing process. It is clinically 
characterized by erythematous and ulcerative lesions that 
affect the vermilion of the lips and oral mucosa (Smith 
et al., 2007).
The use of medicinal plants and herbal medicines 
represents a good alternative treatment approach for 
this patient group. Products containing Aloe vera L., 
Leptospermum scoparium J.R. & G. Forst and Kunzea 
ericoides A. Rich have been used to treat oral mucositis 
with satisfactory results (Rodriguez-Caballero et al., 2012; 
Freitas, Rodrigues, Gaspi, 2014.). Chamomile has been 
used in the treatment of OM with promising results (Dos 
Reis et al., 2016; Braga et al., 2015; Curra et al., 2013; 
Pavesi et al., 2011)
Also, Hypericum perforatum L. extract, whose 
phytocomplex contains borneol, has shown anti-
inflammatory and healing action in oral mucositis 
animal models both systemically and locally through 
oral gel (Tanideh et al., 2014). Borneol (Figure 1) is a 
monoterpene, bicyclic aromatic alcohol, present in many 
essential oils of medicinal plants of the Dipterocarpaceae, 
Lamiaceae (Rosmarinus officinalis L., Thymus vulgaris 
L. and Salvia officinalis L.) (Dipterocarpus turbinatus 
Gaertn.) Valerianaceae (Valeriana officinalis L.) and 
Asteraceae (Matricaria chamomilla L.) families 
(Horváthová et al., 2009; Borges et al., 2012). In 
Chinese and Indian folk medicine, borneol is used in the 
treatment of sore throats, mouth sores, wounds, burns 
and skin infections (Liu et al., 2009; Kong et al., 2014). 
Some studies indicate that borneol has analgesic, anti-
inflammatory, antioxidant, antibacterial and healing 
actions (Horváthová et al., 2009; Liu et al., 2009; 
Barreto, 2013).
Although borneol has been shown to be effective 
in lesions of the oral cavity, the literature reports no pre-
clinical models demonstrating its action in oral mucositis. 
In order to fill this gap, the present study was conducted 
investigating the action of gels containing borneol in 
5-Fluorouracil-induced oral mucositis using an animal 
model with Wistar rats.
MATERIAL AND METHODS
Plant Material
(+)-Borneol 97% was obtained in isolated and 
powder form (420247 - Sigma Aldrich, USA), Synonym: 
endo-(1R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol; 
CAS Number: 464-43-7; Empirical Formula: C10H18O; 
Molecular Weight 154.25; Lot # BGBB9812V.
Preparation of Aristoflex® gels containing 
borneol and stability tests
Aristoflex polymer was mixed with methylparaben 
in water at ambient temperature under stirring at 400 
rpm (Heidolph RZR stirrer, Germany) for 30 minutes to 
complete gelation. The mixture was then incorporated 
into (+)-borneol powder (Sigma-Aldrich, USA) at 
concentrations of 1.2% and 2.4%. The gels thus obtained 
(30 g each, containing borneol at concentrations of 0%, 
1.2% and 2.4%) were packaged, labeled and analyzed for 
organoleptic (appearance, color and odor) and physico-
chemical (pH, conductivity and viscosity) parameters and 
also for both primary and accelerated stability (Oliveira, 
2009).
Animals
Male Wistar rats (300-350 g, 12-16 weeks, n=48) 
were acclimatized for six days prior to experiments and 
housed during the experimental period at 22±2 °C under 
a 12/12h light-dark cycle with access to feed and water ad 
libitum. After the onset of oral mucositis, the animals were 
tagged and randomly distributed into four subgroups of 12 
animals each: G1 Group (Borneol 0%); G2 Group (Borneol 
1.2%); G3 Group (Borneol 2.4%); and G4 group (Control). 
All animals were weighed at the beginning and end of the 
experiment for clinical evaluation. Another 24 animals 
were used in pilot tests for dose and technique adjustments, 
but not included in the results of the study. The project was 
submitted to the Research Ethics Committee on the use 
of animals (CEUA - UNIVASF) and was approved under 
permit 0001/140814 on June 2nd, 2015. 
Chemotherapy-induced oral mucositis
Oral mucositis was induced by administration 
of the 5-fluorouracil chemotherapy drug (Eurofarma, 
São Paulo, Brazil) on days 0, 2 and 4 (30 mg/kg, i.p.) 
according to Lima et al. (2015). On day two, the animals 
were anesthetized [ketamine hydrochloride 10% (50 mg/
FIGURE 1 - Chemical structure of borneol (monoterpene, 
bicyclic aromatic alcohol).
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kg) and xylazine hydrochloride 2% (5 mg/kg i.p.), 0.4 ml 
per animal] and right cheek mucous chemically injured by 
applying 9 mm2 filter paper soaked in 10 µL of solution 
[glacial acetic acid 96% (50%, v/v) in distilled water] for 
60 seconds (Figures 2A, 2B and 2C).
Treatment subgroups
The G1, G2 and G3 Groups received a daily 
application of gels at concentrations of 0%, 1.2% and 
2.4%, respectively, using disposable flexible swabs 
(Figure 2D). The G4 Group (Control) received topical 
application with distilled water. After the application, all 
animals were prevented from drinking water or eating for 
30 minutes to allow time for the gels to act (Tanideh et al., 
2014). The treatments were administered from the third to 
13th day after injury with acetic acid.
Mucous removal and histology procedure
Six animals from each group were sacrificed by 
deep anesthesia [ketamine hydrochloride 10% (100 mg/
kg) and xylazine hydrochloride 2% (10 mg/kg) i.p., 0.5 
mLper animal] on days seven and fourteen after injury. 
Subsequently, right cheek mucous was removed from each 
animal with surgical scissors and scalpel blade number 15 
and placed in 10% neutral buffered formalin solution for 
48h (Akgullu et al., 2015).
Specimens were dehydrated, diaphonized, embedded 
in paraffin and cut transversely into 5 µm-thick slices on 
a microtome (Leica Biosystems, Wetzlar, Germany). 
Mucous samples were stained with hematoxylin-eosin 
(HE) and Masson’s trichrome. All sections were mounted 
on glass slides with cover slips using Entellan (Merck, 
Darms tadt, Germany) for microscopy.
FIGURE 2 - Experimental procedure for testing. A. Placement of filter paper soaked in 50% acetic acid; B. Contact time with cheek 
mucosa of 60 s; C. Aspect of standardized lesion (9 mm2) after filter paper removal; D. Appearance of gels used in treatments.
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Histological evaluation
Fields were scanned using a Leica® DM2500 
microscope (Leica Biosystems, Wetzlar, Germany) under 
x4 and x10 objective lenses, coupled to a CELESTRON® 
Digital Microscope Imager Model 44421 camera 
(Torrance, California, United States) using the software 
supplied with the digital camera. The same light intensity 
was used in all digitalization; images were acquired in 
RGB format at a resolution of 2048 X 1536 pixels with 
JPEG extension. For quantitative analysis, the ImageJ® 
program was employed using the plugin “Cell Counter” 
and the number of inflammatory cells and amount of blood 
vessels stained with HE on the slides were measured. 
To evaluate percentage collagen, the slides stained 
with Masson’s trichrome were photographed and then 
processed using ImageJ® and the Threshold plugin to 
measure percentage collagen at the injury site (Vilela-
Goulart et al., 2008).
The semiquantitative analysis was performed by a 
blinded evaluator who observed inflammatory parameters 
including presence of cellular inflammatory infiltrate, 
vasodilatation, necrosis, ulceration, abscess, hemorrhage 
and edema. These parameters were attributed scores of 
0-3, as described by Lima et al. (2005): Score 0 - normal 
epithelium and connective tissue without vasodilatation; 
absence of, or mild, cellular infiltration; absence of 
hemorrhagic areas, ulcerations or abscesses; Score 1 - 
mild vascular ingurgitation, re-epithelization areas; mild 
inflammatory infiltration with mononuclear prevalence; 
absence of hemorrhagic areas, edema, ulcerations or 
abscesses; Score 2 - moderate vascular ingurgitation, 
areas of hydropic epithelial degeneration, inflammatory 
infiltration with neutrophil prevalence, presence of 
hemorrhagic areas, edema and some ulcerations, absence 
of abscesses; Score 3 - severe vascular ingurgitation 
and dilatation, inflammatory infiltration with neutrophil 
prevalence, presence of hemorrhagic areas, edema and 
extensive ulceration and abscesses.
Statistical analysis
Comparisons for all variables were performed 
independent of day, between days, independent of group 
and between groups. Quantitative and semiquantitative 
variables were expressed as means. For comparisons, the 
two-way ANOVA test, followed by Tukey’s post-test, was 
used for comparisons. In all tests, p≤0.05 was adopted for 
the level of rejection of the null hypothesis for significant 
values.
RESULTS AND DISCUSSION
The formulation developed was stable and 
transparent with a smooth texture, homogeneous 
appearance and characteristic aroma. Borneol 0% had pH 
= 5.0; Conductivity=100.0 mV; Viscosity=58,500 mPa.s; 
and centrifugation without phase separation. Borneol 
1.2% had a pH = 4.7 ± 0.1; Conductivity=120.2 ± 0.5 
mV; Viscosity=45,360 mPa.s; and centrifugation without 
phase separation. Borneol 2.4% had a pH=4.5±0.2; 
Conductivity=139.0±1.5 mV; Viscosity=55,560 mPa.s; 
and centrifugation without phase separation. Acid pH 
values were expected because the Aristoflex® gel base 
was formulated with a pH of 5.0. In a previous study, the 
same gel base had a pH of around 5.0, no phase change 
and good viscosity (Russo, Guimarães, Cardoso, 2008). 
Furthermore, borneol is also considered an acid pH 
substance (Xiao-Fei et al., 2008). Dantas et al. (2016) 
used a topical gel formulation with 5% borneol which 
had a pH of 3.95.
At day seven, a statistically significant difference 
(p <0.05) in scores was found for the G3 group (Borneol 
2.4%) compared with both the G1 (Borneol 0%) and G4 
(Control) groups. This result indicated better healing 
for Borneol 2.4% (Figure 3). G1 Group (Borneol 0%) 
exhibited extensive ulcers and hydropic degeneration, 
spongiosis and exocytosis. Connective tissue (CT) showed 
moderate and diffuse presence of polymorphonuclear 
cells (PMNs) with areas of necrosis and bleeding. The G2 
Group (Borneol 1.2%) showed ulcerated areas, hydropic 
degeneration, spongiosis and exocytosis. CT showed areas 
of necrosis, presence of some congested blood vessels, as 
well as moderate and diffuse presence of PMNs. The G3 
FIGURE 3 - Cicatrization score according to groups and days of 
experimentation. p<0,05: Control vs. Borneol 2.4% (7 days) ; 
p<0,05: Borneol 0% vs. Borneol 2.4% (7 days). p<0,05: Control 
vs. Borneol 2.4% (14 days). p<0,05: Borneol 0% vs. Borneol 
2.4% (14 days). (Mann-Whitney test).
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Group (Borneol 2.4%) had discrete hydropic degeneration, 
spongiosis, and partial reepithelialization in five animals. 
CT showed PMNs and the presence of few congested 
blood vessels. The G4 Group (Negative control) exhibited 
ulcerated areas, hydropic degeneration, spongiosis and 
intense exocytosis. CT had edema and necrosis, moderate 
congested blood vessels, as well as moderate and diffuse 
presence of PMNs (Figure 4).
At day 14, a statistically significant difference (p 
<0.05) in scores was found for the G3 group (Borneol 
2.4%) compared with both the G1 (Borneol 0%) and G4 
(Control) groups. This result indicated better healing 
for Borneol 2.4% (Figure 3). G1 Group (Borneol 0%) 
showed hyperkeratosis and full reepithelialization. CT had 
congested blood vessels, as well as moderate and diffuse 
presence of Mononuclear (MN) cells. The G2 Group 
(Borneol 1.2%) showed reepithelialization but with more 
blood vessels in G3. CT showed numerous clogged blood 
vessels and a diffuse mild chronic inflammatory process. 
The G3 Group (Borneol 2.4%) had a normal aspect and 
full reepithelialization. CT showed normal features, in 
addition to granulation tissue with fibroblasts, congested 
blood vessels and discrete, diffuse presence of MN. The 
G4 Group (Negative Control) had acanthosis (thickened 
spinous layer) with loss of integrity of basal membrane 
and exocytosis. Epithelialization occurred with different 
morphology in four animals. The CT was found to contain 
a large amount of granulation tissue with fibroblasts, 
congested blood vessels and chronic inflammatory 
infiltrate (Figure 5).
At seven days, the group treated with Borneol 2.4% 
showed a lower number of vessels than the other groups 
(G1, G2 and G4). The G3 Group showed statistical 
significance (p<0.05) when compared to the three other 
FIGURE 4 - Microscopic aspects of groups at seven days of experimentation. A Group treated with gel base (Borneol 0%); 
B Group treated with gel (Borneol 1.2%); C Group treated with gel (Borneol 2.4%); and D Group (Negative control). 
PMN=Polymorphonuclear cells; BV=Blood vessel; U=Ulcerated area; E=Exocytosis; ED=edema. Magnification x10. HE staining.
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groups. The G2 Group (Borneol 1.2%) showed statistically 
significant differences when compared to both the G1 
Group (Borneol 0%) and Control Groups. There were no 
differences between the G1 and Control Groups. At 14 
days, there was statistical significance between all cross 
comparisons except the G1 Group and Control Group 
(Figure 6).
While healing depends on the neoformation of blood 
vessels, persistent or excessive vessels may denote the 
existence of chronic inflammation or fibrosis (Abbas et al., 
2010). On histological analysis of the blood vessels, the 
Control Group showed a greater number of blood vessels 
in the final process of wound healing compared to the other 
groups (G2 and G3). This indicates that the healing process 
in the Control Group required a greater angiogenesis for 
the formation of granulation tissue (Abruceze, 2013). 
The proliferation of blood vessels is stimulated by 
vascular endothelial growth factor (VEGF). Some factors 
stimulate the expression of VEGF in angiogenesis and 
ischemia, while increases in certain growth factors are 
responsible for the elevated VEGF expression in chronic 
inflammation and wound healing. The inflamed tissue is 
generally in hypoxia, where inflammation may promote 
angiogenesis by inducing the release of angiogenic 
factors leading to fibrosis (Nagy, Dvorak, Devorak, 2007). 
According to a study by Dai et al. (2009), borneol showed 
anti-fibrotic action.
Regarding inflammatory cell count, the gels 
containing borneol at concentrations of 1.2% and 2.4% 
exhibited anti-inflammatory action at seven and 14 days, 
reducing the number of these cells at the injury site. The 
Control Group and Borneol 0% groups, at seven days, 
showed a much more intense inflammatory process than 
the treated groups (Borneol 1.2% and Borneol 2.4%), but 
FIGURE 5 - Microscopic aspects of groups at fourteen days of experimentation. A Group treated with gel base (Borneol 0%); B 
Group treated with gel (Borneol 1.2%); C Group treated with gel (Borneol 2.4%); and D Group (Control). RE-=reepithelialization; 
HK=Hyperkeratinization; BV=Blood Vessel; MN=Mononuclear; AC=acanthosis. Magnification x10. HE staining.
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(2013), in which the authors confirmed the action of 
monoterpene and suggested that the substance has 
therapeutic potential in painful and inflammatory diseases. 
Tanideh et al. (2014) tested the action of Hypericum 
perforatum L. extract for treating induced oral mucositis 
in animals. The extract of this plant contains Borneol (CIV, 
2012) and was administered by gavage (systemically) 
and locally via an oral gel. The extract showed anti-
inflammatory and healing action, especially systemically.
In the present study, percentage collagen at seven 
days showed statistical significance on comparison of 
the G1 Group (Borneol 0%) with the G3 Group (Borneol 
2.4%) and also on comparisons of the G2 Group and G3 
Group with the G4 Group (Control). Comparison of the G2 
and G3 Groups with the G4 Group also proved significant 
at 14 days (Figure 8). 
Percentage collagen in the G2 and G3 Groups 
on slides stained with Masson’s trichrome was higher 
than in both G1 and G4 Groups at 14 days. This was 
due to the healing effect of borneol which promoted 
greater formation of fibroblasts with better collagen and 
fibronectin production in local lesions (Figure 9). Tanideh 
et al. (2014) also observed increased stimulation of 
collagen production by topical gel Hypericum perforatum 
L., which helped repair the wounds, closing areas of 
damaged oral mucosa in the animals. This effect may be 
associated with the bactericidal action of borneol, which 
prevents secondary infection by fungi and bacteria, 
promoting reepithelialization and standardization of 
collagen fiber content (Tabanca et al., 2001; Wenqiang 
et al., 2006).
FIGURE 6 - Vessel count according to group and day of 
experimentation on anti-inflammatory activity test of oral gel 
containing different concentrations of borneol. ap<0.05: Control 
vs. Borneol 1.2% and Borneol 2.4% (7 days) ; bp<0.05: Borneol 
0% vs. Borneol 1.2% and Borneol 2.4% (7 days). cp<0.05: 
Control vs. Borneol 1.2% and Borneol 2.4% (14 days). dp<0.05: 
Borneol 0% vs. Borneol 1.2% and Borneol 2.4% (14 days) 
(Two-Way Analysis of Variance ANOVA, followed by Tukey’s 
post-test).
FIGURE 8 - Percentage collagen according to group. ap<0.05: 
Control vs. Borneol 1.2% and Borneol 2.4% (7 days) ; bp<0.05: 
Borneol 0% vs. Borneol 2.4% (7 days). cp<0.05: Control vs. 
Borneol 1.2% and Borneol 2.4% (14 days). dp<0.05: Borneol 
0% vs. Borneol 2.4% (14 days) (Two-Way Analysis of Variance 
ANOVA, followed by Tukey’s post-test).
no differences were observed between the two borneol 
concentrations. Cell infiltrates were less intense in all 
groups at 14 days. Differences were observed between the 
G1 Group and G3 Group and also between the two gels 
(Borneol 1.2% and Borneol 2.4%) compared to the Control 
Group, but no differences between the two concentrations 
were evident (Figure 7). 
The findings for number of inflammatory cells 
corroborate the results of the study by Almeida et al. 
FIGURE 7 - Inflammatory cell count according to group and day 
of experimentation. ap<0.05: Control vs. Borneol 0%, Borneol 
1.2% and Borneol 2.4% (7 days) ; bp<0.05: Borneol 0% vs. 
Borneol 1.2% and Borneol 2.4% (7 days). cp<0.05: Control vs. 
Borneol 1.2% and Borneol 2.4% (14 days) (Two-Way Analysis 
of Variance ANOVA, followed by Tukey’s post-test). 
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All animals lost weight throughout the experiment 
due to the side effects of 5-fluorouracil, oral mucositis 
and reduction in water and feed intake. At 14 days of 
experimentation, the Borneol 2.4% Group had a lower 
percentage of weight loss relative to the other three groups 
(Borneol 0%, Borneol 1.2% and Control), probably 
due to the greater action of Borneol 2.4% in reducing 
inflammation and promoting wound healing (Figure 10).
CONCLUSIONS
The Borneol 2.4% Group was statistically superior 
to the Borneol 1.2%, Borneol 0% and Control Groups in 
the treatment of induced oral mucositis in rats, promoting 
angiogenesis control, inflammatory cell count reduction at 
the injury site and percentage neoformed collagen increase 
in reepithelialization. The G3 group (Borneol 2.4%) was 
FIGURE 9 - Microscopic aspects of groups at fourteen days of experimentation. G1 Group treated with gel base (Borneol 0%); 
G2 Group treated with gel (Borneol 1.2%); G3 Group treated with gel (Borneol 2.4%); and G4 Group (Control). Note the greater 
quantity of newly formed collagen in treated groups (G2 and G3). Magnification x10. Masson’s trichrome.
FIGURE 10 - Percentage weight loss according to group and 
day of experimentation. ap<0.05: Control vs. Borneol 1.2% and 
Borneol 2.4% (14 days). bp<0.05: Borneol 0% vs. Borneol 1.2% 
and Borneol 2.4% (14 days) (Two-Way Analysis of Variance 
ANOVA, followed by Tukey’s post-test). 
statistically superior to the other three groups on the 
semiquantitative evaluation, promoting improvement in 
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reepithelialization and healing of chemotherapy-induced 
oral mucositis.
The confirmation of anti-inflammatory and healing 
action of borneol (especially Borneol 2.4%) in oral 
mucositis in rats renders it a good marker for predicting 
this activity for plant extracts rich in this substance. The 
study results showed that borneol has anti-inflammatory 
and healing action in induced oral mucositis in cheek 
mucosa of Wistar rats.
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